Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor–independent pathways
Jamie Cameron, Trond P. Leren(Oslo University Hospital), Thea Bismo Strøm(Oslo University Hospital), Kirsten B. Holven(University of Oslo), Kristian Tveten(Telemark Hospital), Martin P. Bogsrud(Oslo University Hospital), Knut Erik Berge
Cited by 36
Related Papers
De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability
|The American Journal of Human Genetics|2017|202
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry
|European Heart Journal|2019|188
Clinical exome sequencing reveals locus heterogeneity and phenotypic variability of cohesinopathies
|Genetics in Medicine|2018|91
Next-generation sequencing of the monogenic obesity genes LEP , LEPR , MC4R , PCSK1 and POMC in a Norwegian cohort of patients with morbid obesity and normal weight controls
|Molecular Genetics and Metabolism|2017|68
De novo substitutions of TRPM3 cause intellectual disability and epilepsy
|European Journal of Human Genetics|2019|68